Summary: Transcranial Magnetic Stimulation (TMS) has offered relief for many people with treatment-resistant depression, but exactly how it works at the level of neurons and circuits was unclear. New research from UCLA reveals that an accelerated form of TMS, called aiTBS, can physically repair brain circuits damaged by chronic stress, restoring synaptic connections and producing rapid antidepressant effects.
Using a novel preclinical model that closely mimics clinical stimulation, researchers observed that previously lost synaptic structures reappear within 24 hours of stimulation. The team identified intratelencephalic (IT) neurons in the prefrontal cortex as the primary targets of this recovery, providing a structural explanation for why aiTBS produces both fast and durable behavioral benefits.
Key Facts
- Structural scaffolding: Chronic stress causes neurons in the prefrontal cortex to lose dendritic spines—small protrusions that serve as the physical sites for synaptic communication.
- Cellular precision: Rather than producing a broad, nonspecific effect across cell types, aiTBS selectively restored dendritic spines and activity in intratelencephalic (IT) neurons while leaving neighboring neuron types largely unchanged.
- Accelerated protocol (aiTBS): Traditional TMS protocols typically require several weeks of daily sessions; the accelerated intermittent theta burst stimulation (aiTBS) condenses treatment into five days. In the UCLA mouse model, a single day of stimulation produced measurable structural repair and behavioral improvement.
- Essential circuitry: When IT neuron activity was selectively blocked during stimulation, the antidepressant effects disappeared, indicating these neurons are necessary for the therapy’s behavioral benefits.
- Durable changes: Structural restoration in IT neurons remained stable and behavioral improvements persisted for at least one week after a single day of stimulation, suggesting aiTBS restores underlying circuit architecture rather than briefly boosting activity.
Source: UCLA
Background: Transcranial magnetic stimulation is a non-invasive, FDA-approved therapy that applies brief magnetic pulses through a coil placed on the scalp to modulate brain activity. It is commonly used for depression that has not responded to medication, but the exact cellular and circuit mechanisms producing clinical benefit have been difficult to pin down.
A multidisciplinary team from the UCLA Neuromodulation Division has now opened that black box. Their study, published in Cell, describes a first-of-its-kind preclinical approach that replicates clinical stimulation in awake mice. The model allowed researchers to deliver accelerated intermittent theta burst stimulation (aiTBS), monitor neural activity in real time, and image synaptic structures before and after stress and treatment.
The investigators exposed mice to chronic stress to model depression-related changes. They found that stress broadly reduced dendritic spine density across multiple neuron classes in the prefrontal cortex. Remarkably, a single day of aiTBS rapidly reversed these losses—but only in a distinct population of neurons: intratelencephalic (IT) projection neurons. Those same neurons also showed restored activity patterns during behaviors linked to stress and depression.
“We expected a general effect across the prefrontal cortex, but the recovery was surprisingly specific,” said Michael Gongwer, the study’s first author. “Watching synaptic structures re-emerge and then seeing those exact cells regain function during behavior was striking.”
When the team selectively prevented IT neurons from activating during stimulation, the behavioral benefits of aiTBS were abolished, demonstrating that IT neuron engagement is required for the antidepressant effect. The restored dendritic spines and normalized circuit activity persisted for days after stimulation, indicating that aiTBS can rebuild structural elements that support normal circuit function and adaptive behavior rather than producing a short-lived change in excitability.
“Stress erodes the physical scaffolding neurons use to communicate,” said Dr. Laura DeNardo. “By rebuilding those scaffolds in specific cells, stimulation can reactivate the circuits that help animals respond adaptively.”
The study was co-led by Dr. Scott Wilke and Dr. Laura DeNardo and brings together clinical observations and cellular-level neuroscience methods. Wilke noted that these results link the rapid clinical improvements some patients experience with concrete, measurable changes in neuronal architecture.
Although animal models cannot capture every aspect of human depression, this work supplies strong mechanistic evidence that targeted brain stimulation can rapidly restore synaptic connections and circuit function. Those insights could guide refinement of stimulation parameters and the development of more precise neuromodulation therapies for depression and other disorders rooted in circuit dysfunction, such as OCD, PTSD, chronic pain, and tinnitus.
“Every patient’s brain is different,” Wilke said. “Studying how specific stimulation patterns reshape defined neural circuits in preclinical models will help us tailor neuromodulation approaches so they are more effective and longer lasting for individual patients.”
Key Questions Answered:
A: At present, TMS is mainly FDA-approved for treatment-resistant depression, after medication or psychotherapy have failed. As accelerated protocols become more common and we better understand which cells and circuits they target, aiTBS and similar approaches may be considered earlier in treatment for some patients.
A: Yes. TMS is already used clinically for a range of disorders linked to dysfunctional brain circuits. Because many psychiatric and neurological conditions involve disrupted synaptic connectivity, the ability of stimulation to restore dendritic spines in targeted neurons could improve long-term outcomes across disorders.
A: In the study, structural changes remained stable for at least one week after a single day of aiTBS. In clinical practice, some patients experience relief lasting months or years, while others require periodic maintenance sessions. More research will clarify how long synaptic restoration endures and what determines long-term durability in humans.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The journal paper was reviewed in full by the editorial team.
- Additional context and explanatory detail were added by staff to clarify the findings.
About this TMS and depression research news
Author: Will Houston
Source: UCLA
Contact: Will Houston – UCLA
Image: The image is credited to Neuroscience News
Original Research: The findings appear in Cell.